FGFR1, FGFR2 and FGFR3 fusions are also identified in solid tumours, such as lung, colorectal, glioblastoma, breast, head and neck, bladder, cervical cancer and cholangiocarcinoma (as reviewed by [164]). Here, FGFR2 is linked to cholangiocarcinoma.